Gut Microbiota Modulation as a Novel Therapeutic Strategy in Cardiometabolic Diseases

Gut Microbiota Modulation as a Novel Therapeutic Strategy in Cardiometabolic Diseases

The human gut harbors microbial ecology that is in a symbiotic relationship with its host and has a vital function in keeping host homeostasis. Inimical alterations in the composition of gut microbiota, known as gut dysbiosis, have been associated with cardiometabolic diseases. Studies have revealed...

Full description

Bibliographic Details
Main Authors: Yahkub Babatunde Mutalub, Monsurat Abdulwahab, Alkali Mohammed, Aishat Mutalib Yahkub, Sameer Badri AL-Mhanna, Wardah Yusof, Suk Peng Tang, Aida Hanum Ghulam Rasool, Siti Safiah Mokhtar
Format: Article
Language:English
Published: MDPI AG 2022-08-01
Series:Foods
Subjects:
dysbiosis
cardiovascular disease
metabolic disease
probiotics
prebiotics
drug development
Online Access:https://www.mdpi.com/2304-8158/11/17/2575

Internet

https://www.mdpi.com/2304-8158/11/17/2575

Similar Items